PMID- 26861418 OWN - NLM STAT- MEDLINE DCOM- 20161213 LR - 20161230 IS - 1873-7544 (Electronic) IS - 0306-4522 (Linking) VI - 320 DP - 2016 Apr 21 TI - NMDA and non-NMDA glutamate receptors in the paraventricular nucleus of the hypothalamus modulate different stages of hemorrhage-evoked cardiovascular responses in rats. PG - 149-59 LID - S0306-4522(16)00118-4 [pii] LID - 10.1016/j.neuroscience.2016.02.003 [doi] AB - Here we report the involvement of N-Methyl-d-Aspartate (NMDA) and non-NMDA glutamate receptors from the paraventricular nucleus of the hypothalamus (PVN) in the mediation of cardiovascular changes observed during hemorrhage and post-bleeding periods. In addition, the present study provides further evidence of the involvement of circulating vasopressin and cardiac sympathetic activity in cardiovascular responses to hemorrhage. Systemic treatment with the V1-vasopressin receptor antagonist dTyr(CH2)5(Me)AVP (50 mug/kg, i.v.) increased the latency to the onset of hypotension during hemorrhage and slowed post-bleeding recovery of blood pressure. Systemic treatment with the beta1-adrenergic receptor antagonist atenolol (1 mg/kg, i.v.) also increased the latency to the onset of hypotension during hemorrhage. Moreover, atenolol reversed the hemorrhage-induced tachycardia into bradycardia. Bilateral microinjection of the selective NMDA glutamate receptor antagonist LY235959 (2 nmol/100 nL) into the PVN blocked the hypotensive response to hemorrhage and reduced the tachycardia during the post-hemorrhage period. Systemic treatment with dTyr(CH2)5(Me)AVP inhibited the effect of LY235959 on hemorrhage-induced hypotension, without affecting the post-bleeding tachycardia. PVN treatment with the selective non-NMDA receptor antagonist NBQX (2 nmol/100 nL) reduced the recovery of blood pressure to normal levels in the post-bleeding phase and reduced hemorrhage-induced tachycardia. Combined blockade of both NMDA and non-NMDA glutamate receptors in the PVN completely abolished the hypotensive response in the hemorrhage period and reduced the tachycardiac response in the post-hemorrhage period. These results indicate that local PVN glutamate neurotransmission is involved in the neural pathway mediating cardiovascular responses to hemorrhage, via an integrated control involving autonomic nervous system activity and vasopressin release into the circulation. CI - Copyright (c) 2016 IBRO. Published by Elsevier Ltd. All rights reserved. FAU - Busnardo, C AU - Busnardo C AD - Department of Pharmacology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil. Electronic address: crisbus@usp.br. FAU - Crestani, C C AU - Crestani CC AD - School of Pharmaceutical Sciences, Univ. Estadual Paulista-UNESP, Araraquara, SP, Brazil. FAU - Fassini, A AU - Fassini A AD - Department of Pharmacology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil. FAU - Resstel, L B M AU - Resstel LB AD - Department of Pharmacology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil. FAU - Correa, F M A AU - Correa FM AD - Department of Pharmacology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160206 PL - United States TA - Neuroscience JT - Neuroscience JID - 7605074 RN - 0 (Receptors, Glutamate) SB - IM MH - Animals MH - Cardiovascular System/*physiopathology MH - Disease Models, Animal MH - Hemodynamics/*physiology MH - Hemorrhage/*complications MH - Male MH - Paraventricular Hypothalamic Nucleus/*metabolism MH - Rats MH - Rats, Wistar MH - Receptors, Glutamate/*metabolism OTO - NOTNLM OT - cardiovascular system OT - glutamate neurotransmission OT - hemorrhagic shock OT - paraventricular nucleus of hypothalamus OT - sympathetic activity OT - vasopressin EDAT- 2016/02/11 06:00 MHDA- 2016/12/15 06:00 CRDT- 2016/02/11 06:00 PHST- 2015/10/19 00:00 [received] PHST- 2016/01/18 00:00 [revised] PHST- 2016/02/01 00:00 [accepted] PHST- 2016/02/11 06:00 [entrez] PHST- 2016/02/11 06:00 [pubmed] PHST- 2016/12/15 06:00 [medline] AID - S0306-4522(16)00118-4 [pii] AID - 10.1016/j.neuroscience.2016.02.003 [doi] PST - ppublish SO - Neuroscience. 2016 Apr 21;320:149-59. doi: 10.1016/j.neuroscience.2016.02.003. Epub 2016 Feb 6.